Gossamer Bio, Inc. (GOSS) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は Omega Fund V, L.P. 6,553,416 株保有. その他の主要保有者には Hasnain Faheem および Aranda Richard.
過去12ヶ月間にインサイダーは 16 件の取引を実施 GOSS 株式 — 10 件の買い (評価額 $938.4K) および 0 件の売り (評価額 RSU アワード). インサイダーの買いが売りを上回っており、会社の見通しに対する自信の表れかもしれません.
GOSS インサイダー保有状況
最大保有者
Omega Fund V, L.P.
6,553,416 株
インサイダー上位保有者
| # |
氏名 |
役職 |
保有株数 |
最終申告日 |
相対規模 |
| 1 |
Omega Fund V, L.p. |
10 Percent Owner |
6,553,416 |
2019-09-23 |
|
| 2 |
Hasnain Faheem |
President & CEO |
837,793 |
2026-01-05 |
|
| 3 |
Aranda Richard |
Chief Medical Officer |
463,106 |
2026-01-05 |
|
| 4 |
Christian Waage |
EVP, Tech Ops and Admin |
440,000 |
2025-03-06 |
|
| 5 |
Peterson Caryn |
EVP, Regulatory Affairs |
440,000 |
2025-03-06 |
|
| 6 |
Giraudo Bryan |
COO/cfo |
389,737 |
2026-01-05 |
|
| 7 |
Smith Robert Paul Jr |
Chief Commercial Officer |
260,898 |
2026-01-05 |
|
| 8 |
Salter-cid Luisa |
Chief Scientific Officer |
206,065 |
2021-03-25 |
|
| 9 |
Gujrathi Sheila |
President & CEO |
189,500 |
2020-02-19 |
|
| 10 |
Drynan Skye |
Director |
115,000 |
2025-06-26 |
|
| 11 |
Quisel John D |
Director |
115,000 |
2025-06-26 |
|
| 12 |
Nathan Steven D |
Director |
115,000 |
2025-06-26 |
|
| 13 |
Daniel Thomas O |
Director |
115,000 |
2025-06-26 |
|
| 14 |
Milligan Sandra |
Director |
115,000 |
2025-06-26 |
|
| 15 |
Cox Russell J. |
Director |
115,000 |
2025-06-26 |
|
| 16 |
Carter Laura |
Chief Scientific Officer |
76,263 |
2023-03-20 |
|
| 17 |
Dupont Jakob |
Chief Medical Officer |
46,500 |
2020-02-19 |
|
| 18 |
Burow Kristina |
Director |
35,000 |
2023-06-09 |
|
| 19 |
Gala Renee D |
Director |
35,000 |
2023-06-09 |
|
| 20 |
Bilenker Joshua H. |
Director |
30,000 |
2022-07-15 |
|
最近の取引 (過去12ヶ月)
| 日付 |
氏名 |
役職 |
種類 |
株数 |
株価 |
価値 |
| 2026-03-19 |
Smith Robert Paul Jr |
Chief Commercial Officer |
株式返還 |
562,500 |
$2.88 |
$1.62M |
| 2026-03-19 |
Aranda Richard |
Chief Medical Officer |
株式返還 |
157,500 |
$1.21 |
$190.58K |
| 2026-03-19 |
Peterson Caryn |
EVP, Regulatory Affairs |
株式返還 |
125,000 |
$0.84 |
$104.75K |
| 2026-03-19 |
Giraudo Bryan |
COO/cfo |
株式返還 |
211,500 |
$2.16 |
$456.84K |
| 2026-03-19 |
Christian Waage |
EVP, Tech Ops and Admin |
株式返還 |
70,000 |
$1.36 |
$95.2K |
| 2026-03-19 |
Hasnain Faheem |
President & CEO |
株式返還 |
47,000 |
$12.10 |
$568.7K |
| 2026-01-02 |
Smith Robert Paul Jr |
Chief Commercial Officer |
RSU 付与（制限付株式） |
93,750 |
- |
- |
| 2026-01-02 |
Aranda Richard |
Chief Medical Officer |
RSU 付与（制限付株式） |
93,750 |
- |
- |
| 2026-01-02 |
Giraudo Bryan |
COO/cfo |
RSU 付与（制限付株式） |
115,750 |
- |
- |
| 2026-01-02 |
Hasnain Faheem |
President & CEO |
RSU 付与（制限付株式） |
280,000 |
- |
- |
| 2025-06-25 |
Nathan Steven D |
Director |
RSU 付与（制限付株式） |
115,000 |
$1.36 |
$156.4K |
| 2025-06-25 |
Drynan Skye |
Director |
RSU 付与（制限付株式） |
115,000 |
$1.36 |
$156.4K |
| 2025-06-25 |
Milligan Sandra |
Director |
RSU 付与（制限付株式） |
115,000 |
$1.36 |
$156.4K |
| 2025-06-25 |
Quisel John D |
Director |
RSU 付与（制限付株式） |
115,000 |
$1.36 |
$156.4K |
| 2025-06-25 |
Daniel Thomas O |
Director |
RSU 付与（制限付株式） |
115,000 |
$1.36 |
$156.4K |
| 2025-06-25 |
Cox Russell J. |
Director |
RSU 付与（制限付株式） |
115,000 |
$1.36 |
$156.4K |
